Daily aspirin may help fight prostate cancer, but not breast cancer
(HealthDay)—Two new studies paint a complex portrait of aspirin's impact on cancer risk and mortality, with one suggesting the drug may lower the risk of dying from prostate cancer and the other seeing ...
Cancer
Aug 27, 2012 |
not rated yet |
0
|
Researchers validate molecular signature to predict radiation therapy benefit
Researchers at Moffitt Cancer Center, working with colleagues in Sweden, the Netherlands and Puerto Rico, have validated a radiosensitivity molecular signature that can lead to better radiation therapy decisions for treating ...
Cancer
Aug 16, 2012 |
not rated yet |
0
Denosumab superior to zoledronic acid for breast cancer patients with bone metastases
Treatment with denosumab resulted in a greater reduction in skeletal-related events in patients with breast cancer that spread to the bones compared with zoledronic acid, while also maintaining health-related quality of life, ...
Cancer
Aug 14, 2012 |
not rated yet |
0
|
Grapefruit juice lets patients take lower dose of cancer drug
A glass a day of grapefruit juice lets patients derive the same benefits from an anti-cancer drug as they would get from more than three times as much of the drug by itself, according to a new clinical trial. The combination ...
Cancer
Aug 07, 2012 |
5 / 5 (3) |
0
|
Lower risk of serious side-effects in trials of new targeted drugs
Patients in early clinical trials of new-style targeted cancer therapies appear to have a much lower risk of the most serious side-effects than with traditional chemotherapy, according to a new analysis.
Cancer
Aug 07, 2012 |
not rated yet |
0
Short/long-term analyses deem etanercept safe for psoriasis
(HealthDay) -- Etanercept treatment is well tolerated for psoriasis, with no indication of dose-related or cumulative toxicity in short- or long-term analyses, according to a study published in the August ...
Diseases, Conditions, Syndromes
Jul 29, 2012 |
not rated yet |
0
Breast cancer patients who lack RB gene respond better to neoadjuvant chemotherapy
Breast cancer patients whose tumors lacked the retinoblastoma tumor suppressor gene (RB) had an improved pathological response to neoadjuvant chemotherapy, researchers at Thomas Jefferson University Hospital and the Kimmel ...
Cancer
Jul 26, 2012 |
not rated yet |
0
Certain heart meds may give chemo a boost
(HealthDay) -- When common heart drugs such as digitalis and digoxin are combined with some chemotherapy drugs, the effect appears to be an increase in the death of cancer cells, according to French researchers.
Cancer
Jul 18, 2012 |
not rated yet |
0
|
'Master switch' experimental drug could treat different cancers
(Medical Xpress) -- A unique multi-target experimental drug could treat a range of cancer types, according to research published in Clinical Cancer Research today. ...
Cancer
Jul 11, 2012 |
5 / 5 (1) |
0
|
Cell differentiation as a novel strategy for the treatment of an aggressive type of skin cancer
Skin squamous cell carcinoma (SCC) is a subtype of very aggressive skin cancers that usually develops in sunexposed body regions, but can also affect a large number of organs such as the bladder, esophagus, lungs etc. However, ...
Cancer
Jul 09, 2012 |
not rated yet |
0
Merck KGaA suffers setback on cancer drug
German pharmaceuticals maker Merck KGaA said Thursday that phase III clinical trials of its gastric cancer drug Erbitux had shown no benefits for patients.
Cancer
Jul 05, 2012 |
not rated yet |
0
Research shows new prognosis tool for deadly brain cancer
A diagnosis of glioblastoma multiforme (GBM) is generally a death sentence, but new research from the University of Wisconsin-Madison lab of Dr. John Kuo shows that at least one subtype is associated with a longer life expectancy. ...
Cancer
Jun 20, 2012 |
not rated yet |
0
|
Genetic marker in vitamin D receptor gene associated with increased pancreatic cancer survival
Pancreatic cancer patients with a genetic marker linked to increased expression of the receptor for vitamin D have higher rates of overall survival, according to findings presented at the American Association for Cancer Research's ...
Cancer
Jun 19, 2012 |
not rated yet |
0
Ginseng fights fatigue in cancer patients, study finds
High doses of the herb American ginseng (Panax quinquefolius) over two months reduced cancer-related fatigue in patients more effectively than a placebo, a Mayo Clinic-led study found. Sixty percent of patients studied had ...
Cancer
Jun 04, 2012 |
not rated yet |
0
Clinical trial design supports original accelerated approval of sunitinib for GIST
Patients benefitted from an important design element in the pivotal phase III clinical trial that led to Food and Drug Administration and worldwide regulatory approval of sunitinib for the treatment of gastrointestinal stromal ...
Cancer
Jun 01, 2012 |
not rated yet |
0
